Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-08

Clinical Trial Update: Pharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care Patients

View source ↗

Summary

A terminated clinical trial evaluating the pharmacokinetics and clinical response of tolvaptan in neurocritical care patients with brain injury and hyponatremia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tolvaptan (tolvaptan)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Brain Injury, Hyponatremia | Status: TERMINATED